1. Home
  2. CNDT vs KMDA Comparison

CNDT vs KMDA Comparison

Compare CNDT & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNDT
  • KMDA
  • Stock Information
  • Founded
  • CNDT 2016
  • KMDA 1990
  • Country
  • CNDT United States
  • KMDA Israel
  • Employees
  • CNDT N/A
  • KMDA N/A
  • Industry
  • CNDT Business Services
  • KMDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • CNDT Consumer Discretionary
  • KMDA Health Care
  • Exchange
  • CNDT Nasdaq
  • KMDA Nasdaq
  • Market Cap
  • CNDT 381.9M
  • KMDA 443.4M
  • IPO Year
  • CNDT N/A
  • KMDA N/A
  • Fundamental
  • Price
  • CNDT $2.61
  • KMDA $7.45
  • Analyst Decision
  • CNDT
  • KMDA Strong Buy
  • Analyst Count
  • CNDT 0
  • KMDA 2
  • Target Price
  • CNDT N/A
  • KMDA $13.00
  • AVG Volume (30 Days)
  • CNDT 1.1M
  • KMDA 71.0K
  • Earning Date
  • CNDT 08-06-2025
  • KMDA 08-13-2025
  • Dividend Yield
  • CNDT N/A
  • KMDA 2.71%
  • EPS Growth
  • CNDT N/A
  • KMDA 31.21
  • EPS
  • CNDT 1.54
  • KMDA 0.28
  • Revenue
  • CNDT $3,186,000,000.00
  • KMDA $167,235,000.00
  • Revenue This Year
  • CNDT N/A
  • KMDA $14.51
  • Revenue Next Year
  • CNDT $2.85
  • KMDA $9.31
  • P/E Ratio
  • CNDT $1.69
  • KMDA $27.20
  • Revenue Growth
  • CNDT N/A
  • KMDA 11.83
  • 52 Week Low
  • CNDT $1.90
  • KMDA $5.08
  • 52 Week High
  • CNDT $4.90
  • KMDA $9.16
  • Technical
  • Relative Strength Index (RSI)
  • CNDT 50.88
  • KMDA 48.23
  • Support Level
  • CNDT $2.55
  • KMDA $7.62
  • Resistance Level
  • CNDT $2.66
  • KMDA $7.62
  • Average True Range (ATR)
  • CNDT 0.10
  • KMDA 0.19
  • MACD
  • CNDT -0.03
  • KMDA -0.07
  • Stochastic Oscillator
  • CNDT 35.44
  • KMDA 10.79

About CNDT Conduent Incorporated

Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments namely Commercial Industries which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas of which the majority of revenue is generated in the United States.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: